|
|
3줄모양
|
|
 |
mhxnmbxhinILkfR |
 |
390 |
|
 |
| How long are you planning to stay here? http://xxx-xxxx.in.net/ www xxx In the study, 69% of patients receiving alirocumab experienced side effects, compared to 78% of patients receiving ezetimibe. The most side effects were infections--including influenza and upper respiratory tract infection--which occurred in 42% of patients receiving Regeneron and Sanofi's drug, compared to 39% in the control arm. |
|
 |
Carter |
 |
2019-12-22 08:09:21 |
|
|
|
|
|
|
|
|
|
